Orthopaedic Surgery·Boston, MA

Boston University Medical Center

Signal lift7%33%+26 pp with a signal here
Allocate signal →Track an away here22-26 pooled · applicant-level
Step 2 invited
p10 – p90
Sample N
404
applicant rows
This cycle
no tracked aways yet
Match rate
1.7%
7 of 404 matched
01Cohort funnel2022-26 pooled · applicant-level
N = 404
Applied
404
100.0%
Invited
95
23.5%
Matched
7
1.7%

Steepest cliff: invite → match (93% of invitees did not match here). Interview prep and ranking strategy carry the weight.

02Away rotation impact
-2pp
Non-rotators
26%
119 of 450
Rotators
24%
12 of 50
Interview lift
-2pp
vs not rotating

Rotators got interviewed at 24%, vs 26% for everyone else. If you can secure a rotation here, you've effectively secured the interview.

J-1 visaH-1B visaCategoricalResearch
Your fitBoston University Medical Center Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Boston University Medical Center Program

Create free account
Contact
PI
Program Director
Paul Tornetta III, MD
Email director
LL
Program Coordinator
Lynnette St Louis
Email coordinator
Training sites5 hospitals · Boston
  • 1
    Boston University Medical Center
    Boston, MA
    Primary
  • 2
    Lahey Clinic
    Burlington, MA
    Participant
  • 3
    Veterans Affairs Medical Center (Boston)
    Boston, MA
    Participant
  • 4
    Shriners Hospitals for Children (Springfield)
    Springfield, MA
    Participant
  • 5
    Massachusetts General Hospital
    Boston, MA
    Participant
Interview invites
Loading...
Rotator reports6 reports · paraphrased
mixed hands-onpresentation req.
  • 25-26Rotator in 2025-26 described BU as a hard-working academic program. Mornings start with pre-rounds on each service (~4-4:30am on many teams) before combined 5-6:15am zoom trauma board rounds with faculty. Rotators split 24-hour call during the week and present a weighted end-of-rotation case with literature review. Described as strong didactically with close-knit residents; hours flagged as long.
  • 19-20Rotator in 2019/20 noted all rotators receive an interview on a single January day, with an end-of-rotation presentation in front of faculty and residents.
  • 18-19Two rotators in 2018/19 described an academic blue-collar program with high trauma volume, approachable faculty, strong joints and trauma training, and multiple weekly didactic and skills-lab sessions. Residents worked hard but enjoyed the rotation.
  • 15-16Details withheld for this cycle.
  • 14-15Rotator in 2014/15 described a collegial program with high trauma volume and a desirable city location.

Paraphrased from rotator survey responses. Names and identifying details removed.

Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates
US MD
0%
US DO
0%
US IMG
0%
Non-US IMG
0%
Interview prepOrthopaedic Surgery
specialtyWhy orthopaedics over general surgery?★ common
clinicalDescribe an orthopaedic case that was memorable to you.★ common
specialtyWhat subspecialty are you considering? (Sports, spine, trauma, hand, joints)★ common
behavioralHow do you maintain work-life balance in a surgical specialty?
clinicalTell me about your surgical experience.★ common
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesOrthopaedic Surgery · 25-26
Save this program

Add Boston University Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Orthopaedic Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.